Literature DB >> 9571980

Relationship between psychotropic drugs and thyroid function: a review.

M F Sauvage1, P Marquet, A Rousseau, C Raby, J Buxeraud, G Lachâtre.   

Abstract

Some widely used psychoactive drugs, such as tricyclic antidepressants and antipsychotic phenothiazines exhibit iatrogenic effects on the thyroid. These side effects may arise from interactions at different steps of thyroid hormone biosynthesis. These drugs can induce a change in iodine capture by thyroid cells or can complex iodine, making it unavailable for thyroid hormone synthesis and thus decreasing thyroid hormone blood levels; they can also inhibit thyroid peroxidase activity and thus T3 and T4 synthesis or enhance deiodination of T4 to T3 or to Rt3 by stimulation of deiodinase activity. Moreover, tricyclic antidepressants interfere with the hypothalamic-pituitary-thyroid axis via the noradrenergic or serotonergic systems and might therefore decrease T4 or T3 blood levels, respectively. Phenothiazines can induce autoimmune hypothyroidism, as shown by an increase in the expression of the major histocompatibility complex antigen and by a production of antithyroglobulin or antithyroperoxidase antibodies. However, all these mechanisms are only speculative in humans, as they have only been demonstrated in vitro or in animal experiments. Clinically, thyroid function and affective disorders are closely linked. On one hand, the therapeutic response to antidepressants could be influenced by the thyroid status; on the other hand, the larger the thyroxin decrease induced by antidepressants, the better the therapeutic effect might be. Moreover, cotreatment with thyroid hormones and antidepressant drugs could allow either a decrease in the rate of treatment failure or a faster recovery from depression. As antipsychotic or antidepressant treatments are administered over long periods in humans, their thyroid toxic effects must be taken seriously.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9571980     DOI: 10.1006/taap.1998.8367

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

Review 1.  Serotonin transporters: implications for antidepressant drug development.

Authors:  Kellie J White; Crystal C Walline; Eric L Barker
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

2.  Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors.

Authors:  Michael Gitlin; Lori L Altshuler; Mark A Frye; Rita Suri; Emily L Huynh; Lynn Fairbanks; Michael Bauer; Stanley Korenman
Journal:  J Psychiatry Neurosci       Date:  2004-09       Impact factor: 6.186

3.  Taurine and coenzyme Q10 synergistically prevent and reverse chlorpromazine-induced psycho-neuroendocrine changes and cataleptic behavior in rats.

Authors:  Mega O Oyovwi; Eze K Nwangwa; Benneth Ben-Azu; Tesi P Edesiri; Victor Emojevwe; John C Igweh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-04       Impact factor: 3.000

Review 4.  Subclinical thyroid dysfunction and major depressive disorder.

Authors:  Grigorios N Karakatsoulis; Eva-Maria Tsapakis; Calypso Mitkani; Konstantinos N Fountoulakis
Journal:  Hormones (Athens)       Date:  2021-08-24       Impact factor: 2.885

5.  Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.

Authors:  Fan Zhang; Parisa Kanzali; Vadim Rubin; Chris Paras; Joel Goldman
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

6.  FT4 and TSH, relation to diagnoses in an unselected psychiatric acute-ward population, and change during acute psychiatric admission.

Authors:  Yuki Sakai; Valentina Iversen; Solveig Klæbo Reitan
Journal:  BMC Psychiatry       Date:  2018-07-28       Impact factor: 3.630

7.  Central hypothyroidism related to antipsychotic and antidepressant medications: an observational study and literature review.

Authors:  Frederick Keen; Anuja Chalishazar; Kelly Mitchem; Alan Dodd; Atul Kalhan
Journal:  Eur Thyroid J       Date:  2022-03-08

Review 8.  Pathophysiology and Clinical Features of Neuropsychiatric Manifestations of Thyroid Disease.

Authors:  Marilu Jurado-Flores; Firas Warda; Arshag Mooradian
Journal:  J Endocr Soc       Date:  2022-01-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.